Filtros : "University of Alberta (UAlberta)" "FCF" Removido: "Indexado no Science Citation Index Expanded" Limpar

Filtros



Refine with date range


  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: TRATO GASTROINTESTINAL, FARMACOCINÉTICA, MEDICAMENTO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SILVA, Daniela Amaral et al. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, v. 29, n. 2, p. 62-75, 2022Tradução . . Disponível em: https://doi.org/10.14227/DT290222P62. Acesso em: 05 nov. 2024.
    • APA

      Silva, D. A., Davies, N. M., Bou-Chacra, N. A., Ferraz, H. G., & Löbenberg, R. (2022). Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions. Dissolution Technologies, 29( 2), 62-75. doi:10.14227/DT290222P62
    • NLM

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14227/DT290222P62
    • Vancouver

      Silva DA, Davies NM, Bou-Chacra NA, Ferraz HG, Löbenberg R. Update on gastrointestinal biorelevant media and physiologically relevant dissolution conditions [Internet]. Dissolution Technologies. 2022 ; 29( 2): 62-75.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14227/DT290222P62
  • Source: Journal of Global Antimicrobial Resistance. Unidades: FCF, FM

    Subjects: QUITOSANA, LEISHMANIA, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MONTEIRO, Lis Marie et al. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, v. 18, p. 279-283, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.jgar.2019.06.006. Acesso em: 05 nov. 2024.
    • APA

      Monteiro, L. M., Löbenberg, R., Fotaki, N., Araujo, G. L. B. de, Cotrim, P. C., & Bou-Chacra, N. A. (2019). Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment. Journal of Global Antimicrobial Resistance, 18, 279-283. doi:10.1016/j.jgar.2019.06.006
    • NLM

      Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006
    • Vancouver

      Monteiro LM, Löbenberg R, Fotaki N, Araujo GLB de, Cotrim PC, Bou-Chacra NA. Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment [Internet]. Journal of Global Antimicrobial Resistance. 2019 ; 18 279-283.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.jgar.2019.06.006
  • Source: Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: COMPOSTOS HETEROCÍCLICOS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COMPRI, Jéssica de Cássia Zaghi et al. Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, v. 108, n. 5, p. 1848-1856, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.xphs.2018.12.015. Acesso em: 05 nov. 2024.
    • APA

      Compri, J. de C. Z., Felli, V. M. A., Lourenço, F. R., Takatsuka, T., Fotaki, N., Löbenberg, R., et al. (2019). Highly water-soluble orotic acid nanocrystals produced by high-energy milling. Journal of Pharmaceutical Sciences, 108( 5), 1848-1856. doi:10.1016/j.xphs.2018.12.015
    • NLM

      Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015
    • Vancouver

      Compri J de CZ, Felli VMA, Lourenço FR, Takatsuka T, Fotaki N, Löbenberg R, Bou-Chacra NA, Araujo GLB de. Highly water-soluble orotic acid nanocrystals produced by high-energy milling [Internet]. Journal of Pharmaceutical Sciences. 2019 ; 108( 5): 1848-1856.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.xphs.2018.12.015
  • Source: International Journal of Pharmaceutics. Unidade: FCF

    Subjects: LEISHMANIA, NANOTECNOLOGIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      SOUZA, Aline de et al. Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics, v. 547, n. 1-2, p. 421-431, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2018.06.018. Acesso em: 05 nov. 2024.
    • APA

      Souza, A. de, Marins, D. S. S., Mathias, S. L., Monteiro, L. M., Yukuyama, M. N., Scarim, C. B., et al. (2018). Promising nanotherapy in treating leishmaniasis. International Journal of Pharmaceutics, 547( 1-2), 421-431. doi:10.1016/j.ijpharm.2018.06.018
    • NLM

      Souza A de, Marins DSS, Mathias SL, Monteiro LM, Yukuyama MN, Scarim CB, Löbenberg R, Bou-Chacra NA. Promising nanotherapy in treating leishmaniasis [Internet]. International Journal of Pharmaceutics. 2018 ; 547( 1-2): 421-431.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2018.06.018
    • Vancouver

      Souza A de, Marins DSS, Mathias SL, Monteiro LM, Yukuyama MN, Scarim CB, Löbenberg R, Bou-Chacra NA. Promising nanotherapy in treating leishmaniasis [Internet]. International Journal of Pharmaceutics. 2018 ; 547( 1-2): 421-431.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1016/j.ijpharm.2018.06.018
  • Source: Dissolution Technologies. Unidade: FCF

    Subjects: CÁPSULAS, RUPTURA DOS MATERIAIS, TESTES ENZIMÁTICOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      BACHOUR, Ghada e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, v. 24, n. 2, p. 16-19, 2017Tradução . . Disponível em: https://doi.org/10.14227/DT240217P16. Acesso em: 05 nov. 2024.
    • APA

      Bachour, G., Bou-Chacra, N. A., & Löbenberg, R. (2017). Evaluation of the rupture test for stability studies of soft-shell capsules. Dissolution Technologies, 24( 2), 16-19. doi:10.14227/DT240217P16
    • NLM

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14227/DT240217P16
    • Vancouver

      Bachour G, Bou-Chacra NA, Löbenberg R. Evaluation of the rupture test for stability studies of soft-shell capsules [Internet]. Dissolution Technologies. 2017 ; 24( 2): 16-19.[citado 2024 nov. 05 ] Available from: https://doi.org/10.14227/DT240217P16
  • Source: Pharmaceutical Development and Technology. Unidade: FCF

    Subjects: ESPECTROSCOPIA INFRAVERMELHA, ANÁLISE MULTIVARIADA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      CURTIVO, Cátia Panizzon Dal et al. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study. Pharmaceutical Development and Technology, v. 20, n. 3, p. 345-351, 2015Tradução . . Disponível em: https://doi.org/10.3109/10837450.2013.867448. Acesso em: 05 nov. 2024.
    • APA

      Curtivo, C. P. D., Funghi, N. B., Tavares, G. D., Barbosa, S. F., Löbenberg, R., & Bou-Chacra, N. A. (2015). The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study. Pharmaceutical Development and Technology, 20( 3), 345-351. doi:10.3109/10837450.2013.867448
    • NLM

      Curtivo CPD, Funghi NB, Tavares GD, Barbosa SF, Löbenberg R, Bou-Chacra NA. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 3): 345-351.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3109/10837450.2013.867448
    • Vancouver

      Curtivo CPD, Funghi NB, Tavares GD, Barbosa SF, Löbenberg R, Bou-Chacra NA. The critical role of NIR spectroscopy and statistical process control (SPC) strategy towards captopril tablets (25 mg) manufacturing process understanding: a case study [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 3): 345-351.[citado 2024 nov. 05 ] Available from: https://doi.org/10.3109/10837450.2013.867448
  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Subjects: CROMATOGRAFIA LÍQUIDA DE ALTA EFICIÊNCIA, NANOPARTÍCULAS

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MONTEIRO, Lis Marrie et al. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, v. 51, n. 3, p. 561-567, 2015Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502015000300008. Acesso em: 05 nov. 2024.
    • APA

      Monteiro, L. M., Tavares, G. D., Ferreira, E. I., Consiglieri, V. O., Bou-Chacra, N. A., & Löbenberg, R. (2015). Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles. Brazilian Journal of Pharmaceutical Sciences, 51( 3), 561-567. doi:10.1590/s1984-82502015000300008
    • NLM

      Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/s1984-82502015000300008
    • Vancouver

      Monteiro LM, Tavares GD, Ferreira EI, Consiglieri VO, Bou-Chacra NA, Löbenberg R. Reverse phase high-performance liquid chromatography for quantification of hydroxymethylnitrofurazone in polymeric nanoparticles [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2015 ; 51( 3): 561-567.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/s1984-82502015000300008
  • Source: Journal of Pharmacy Pharmaceutical Sciences. Unidade: FCF

    Subjects: EMULSÕES COSMÉTICAS, CONSERVANTES

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LOURENÇO, Felipe Rebello et al. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion. Journal of Pharmacy Pharmaceutical Sciences, v. 18, n. 3, p. 551-561, 2015Tradução . . Disponível em: https://doi.org/10.18433/J3J600. Acesso em: 05 nov. 2024.
    • APA

      Lourenço, F. R., Francisco, F. L., Ferreira, M. R. S., Pinto, T. de J. A., Löbenberg, R., & Bou-Chacra, N. A. (2015). Design space approach for preservative system optimization of an anti-aging eye fluid emulsion. Journal of Pharmacy Pharmaceutical Sciences, 18( 3), 551-561. doi:10.18433/J3J600
    • NLM

      Lourenço FR, Francisco FL, Ferreira MRS, Pinto T de JA, Löbenberg R, Bou-Chacra NA. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion [Internet]. Journal of Pharmacy Pharmaceutical Sciences. 2015 ; 18( 3): 551-561.[citado 2024 nov. 05 ] Available from: https://doi.org/10.18433/J3J600
    • Vancouver

      Lourenço FR, Francisco FL, Ferreira MRS, Pinto T de JA, Löbenberg R, Bou-Chacra NA. Design space approach for preservative system optimization of an anti-aging eye fluid emulsion [Internet]. Journal of Pharmacy Pharmaceutical Sciences. 2015 ; 18( 3): 551-561.[citado 2024 nov. 05 ] Available from: https://doi.org/10.18433/J3J600
  • Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences. Unidade: FCF

    Assunto: NANOTECNOLOGIA

    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      COMPRI, Jéssica de Cássia Zaghi et al. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 05 nov. 2024. , 2014
    • APA

      Compri, J. de C. Z., Felli, V. M. A., Barbosa, S. F., Morales, I. A. C., Araujo, G. L. B. de, Takatsuka, T., et al. (2014). Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
    • NLM

      Compri J de CZ, Felli VMA, Barbosa SF, Morales IAC, Araujo GLB de, Takatsuka T, Loebenberg R, Bou-Chacra NA. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 30 res. FCF056.[citado 2024 nov. 05 ]
    • Vancouver

      Compri J de CZ, Felli VMA, Barbosa SF, Morales IAC, Araujo GLB de, Takatsuka T, Loebenberg R, Bou-Chacra NA. Orotic acid nanocrystals: preparation and physical-chemical caracterization. Brazilian Journal of Pharmaceutical Sciences. 2014 ; 50 30 res. FCF056.[citado 2024 nov. 05 ]
  • Source: BioMed Research International. Unidade: FCF

    Subjects: SOFTWARES, FARMACOCINÉTICA, FÁRMACOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZUO, Jieyu et al. Evaluation of the DDSolver software applications. BioMed Research International, p. 1-9 art. 204925, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/204925. Acesso em: 05 nov. 2024.
    • APA

      Zuo, J., Gao, Y., Bou-Chacra, N. A., & Löbenberg, R. (2014). Evaluation of the DDSolver software applications. BioMed Research International, 1-9 art. 204925. doi:10.1155/2014/204925
    • NLM

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2014/204925
    • Vancouver

      Zuo J, Gao Y, Bou-Chacra NA, Löbenberg R. Evaluation of the DDSolver software applications [Internet]. BioMed Research International. 2014 ; 1-9 art. 204925.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2014/204925
  • Source: BioMed Research International. Unidade: FCF

    Subjects: PASSIFLORACEAE, ANTI-HISTAMÍNICOS H2

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      STRASSER, Marc et al. Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts. BioMed Research International, p. 1-7 art. 434067, 2014Tradução . . Disponível em: https://doi.org/10.1155/2014/434067. Acesso em: 05 nov. 2024.
    • APA

      Strasser, M., Noriega, P., Löbenberg, R., Bou-Chacra, N. A., & Bacchi, E. M. (2014). Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts. BioMed Research International, 1-7 art. 434067. doi:10.1155/2014/434067
    • NLM

      Strasser M, Noriega P, Löbenberg R, Bou-Chacra NA, Bacchi EM. Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts [Internet]. BioMed Research International. 2014 ; 1-7 art. 434067.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2014/434067
    • Vancouver

      Strasser M, Noriega P, Löbenberg R, Bou-Chacra NA, Bacchi EM. Antiulcerogenic potential activity of free and nanoencapsulated Passiflora serratodigitata L. extracts [Internet]. BioMed Research International. 2014 ; 1-7 art. 434067.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2014/434067
  • Source: AAPS PharmSciTech. Unidade: FCF

    Subjects: BIOEQUIVALÊNCIA, MEDICAMENTO GENÉRICO

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ZUO, Jieyu e BOU-CHACRA, Nadia Araci e LÖBENBERG, Raimar. Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, v. 15, n. 5, p. 1070-1075, 2014Tradução . . Disponível em: https://doi.org/10.1208/s12249-014-0133-8. Acesso em: 05 nov. 2024.
    • APA

      Zuo, J., Bou-Chacra, N. A., & Löbenberg, R. (2014). Challenges and opportunities to use biowaivers to compare generics in China. AAPS PharmSciTech, 15( 5), 1070-1075. doi:10.1208/s12249-014-0133-8
    • NLM

      Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
    • Vancouver

      Zuo J, Bou-Chacra NA, Löbenberg R. Challenges and opportunities to use biowaivers to compare generics in China [Internet]. AAPS PharmSciTech. 2014 ; 15( 5): 1070-1075.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12249-014-0133-8
  • Source: BioMed Research International. Unidade: FCF

    Subjects: NANOPARTÍCULAS, ANTI-INFECCIOSOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      GAO, Yuan et al. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. BioMed Research International, p. 1-9 art. 136590, 2013Tradução . . Disponível em: https://doi.org/10.1155/2013/136590. Acesso em: 05 nov. 2024.
    • APA

      Gao, Y., Zuo, J., Bou-Chacra, N. A., Pinto, T. de J. A., Clas, S. D., Walker, R. B., & Löbenberg, R. (2013). In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus. BioMed Research International, 1-9 art. 136590. doi:10.1155/2013/136590
    • NLM

      Gao Y, Zuo J, Bou-Chacra NA, Pinto T de JA, Clas SD, Walker RB, Löbenberg R. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus [Internet]. BioMed Research International. 2013 ; 1-9 art. 136590.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2013/136590
    • Vancouver

      Gao Y, Zuo J, Bou-Chacra NA, Pinto T de JA, Clas SD, Walker RB, Löbenberg R. In vitro release kinetics of antituberculosis drugs from nanoparticles assessed using a modified dissolution apparatus [Internet]. BioMed Research International. 2013 ; 1-9 art. 136590.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1155/2013/136590
  • Source: Molecular Pharmaceutics. Unidade: FCF

    Subjects: EXTRATOS (FORMAS FARMACÊUTICAS), PLANTAS HERBÁCEAS, SOLUBILIDADE

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      WALDMANN, Sarah et al. Provisional biopharmaceutical classification of some common herbs used in western medicine. Molecular Pharmaceutics, v. 9, n. 4, p. 815-822, 2012Tradução . . Disponível em: https://doi.org/10.1021/mp200162b. Acesso em: 05 nov. 2024.
    • APA

      Waldmann, S., Almukainzi, M., Bou-Chacra, N. A., Amidon, G. L., Beom-Jin, L., Feng, J., et al. (2012). Provisional biopharmaceutical classification of some common herbs used in western medicine. Molecular Pharmaceutics, 9( 4), 815-822. doi:10.1021/mp200162b
    • NLM

      Waldmann S, Almukainzi M, Bou-Chacra NA, Amidon GL, Beom-Jin L, Feng J, Kanfer I, Zuo JZ, Wei H, Bolger MB, Löbenberg R. Provisional biopharmaceutical classification of some common herbs used in western medicine [Internet]. Molecular Pharmaceutics. 2012 ; 9( 4): 815-822.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1021/mp200162b
    • Vancouver

      Waldmann S, Almukainzi M, Bou-Chacra NA, Amidon GL, Beom-Jin L, Feng J, Kanfer I, Zuo JZ, Wei H, Bolger MB, Löbenberg R. Provisional biopharmaceutical classification of some common herbs used in western medicine [Internet]. Molecular Pharmaceutics. 2012 ; 9( 4): 815-822.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1021/mp200162b
  • Source: American Association of Pharmaceutical Scientists. Unidade: FCF

    Assunto: BIOEQUIVALÊNCIA

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      LÖBENBERG, Raimar et al. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, v. 14, n. 3, p. 462-472, 2012Tradução . . Disponível em: https://doi.org/10.1208/s12248-012-9350-9. Acesso em: 05 nov. 2024.
    • APA

      Löbenberg, R., Bou-Chacra, N. A., Stippler, E. S., Shah, V. P., De Stefano, A. J., Hauck, W. W., & Williams, R. L. (2012). Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas. American Association of Pharmaceutical Scientists, 14( 3), 462-472. doi:10.1208/s12248-012-9350-9
    • NLM

      Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12248-012-9350-9
    • Vancouver

      Löbenberg R, Bou-Chacra NA, Stippler ES, Shah VP, De Stefano AJ, Hauck WW, Williams RL. Toward global standards for comparator pharmaceutical products: case studies of amoxicillin, metronidazole, and zidovudine in the americas [Internet]. American Association of Pharmaceutical Scientists. 2012 ; 14( 3): 462-472.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12248-012-9350-9
  • Source: Brazilian Journal of Pharmaceutical Sciences. Unidade: FCF

    Assunto: COMPRIMIDOS (REVESTIMENTOS)

    Acesso à fonteAcesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      MELO JUNIOR, Valdomero Pereira de e LÖBENBERG, Raimar e BOU-CHACRA, Nadia Araci. Statistical evaluation of tablet coating processes: influence of pan design and solvent type. Brazilian Journal of Pharmaceutical Sciences, v. 46, n. 4, p. 657-664, 2010Tradução . . Disponível em: https://doi.org/10.1590/s1984-82502010000400007. Acesso em: 05 nov. 2024.
    • APA

      Melo Junior, V. P. de, Löbenberg, R., & Bou-Chacra, N. A. (2010). Statistical evaluation of tablet coating processes: influence of pan design and solvent type. Brazilian Journal of Pharmaceutical Sciences, 46( 4), 657-664. doi:10.1590/s1984-82502010000400007
    • NLM

      Melo Junior VP de, Löbenberg R, Bou-Chacra NA. Statistical evaluation of tablet coating processes: influence of pan design and solvent type [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46( 4): 657-664.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/s1984-82502010000400007
    • Vancouver

      Melo Junior VP de, Löbenberg R, Bou-Chacra NA. Statistical evaluation of tablet coating processes: influence of pan design and solvent type [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46( 4): 657-664.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1590/s1984-82502010000400007
  • Source: American Association of Pharmaceutical Scientists Journal. Unidade: FCF

    Subjects: SUPLEMENTOS DIETÉTICOS, COMPRIMIDOS

    Acesso à fonteDOIHow to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
    • ABNT

      ALMUKAINZ, May et al. Investigation of the performance of the disintegration test for dietary supplements. American Association of Pharmaceutical Scientists Journal, v. 12, n. 4, p. 602-607, 2010Tradução . . Disponível em: https://doi.org/10.1208/s12248-010-9221-1. Acesso em: 05 nov. 2024.
    • APA

      Almukainz, M., Salehi, M., Bou-Chacra, N. A., & Löbenberg, R. (2010). Investigation of the performance of the disintegration test for dietary supplements. American Association of Pharmaceutical Scientists Journal, 12( 4), 602-607. doi:10.1208/s12248-010-9221-1
    • NLM

      Almukainz M, Salehi M, Bou-Chacra NA, Löbenberg R. Investigation of the performance of the disintegration test for dietary supplements [Internet]. American Association of Pharmaceutical Scientists Journal. 2010 ; 12( 4): 602-607.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12248-010-9221-1
    • Vancouver

      Almukainz M, Salehi M, Bou-Chacra NA, Löbenberg R. Investigation of the performance of the disintegration test for dietary supplements [Internet]. American Association of Pharmaceutical Scientists Journal. 2010 ; 12( 4): 602-607.[citado 2024 nov. 05 ] Available from: https://doi.org/10.1208/s12248-010-9221-1

Digital Library of Intellectual Production of Universidade de São Paulo     2012 - 2024